Illumina ILMN today announced it has entered into a
multi-year supply agreement with Laboratory Corporation of America®
Holdings (LabCorp®) LH. The agreement gives LabCorp expanded
rights to use Illumina next-generation sequencing (NGS) and microarray
equipment and supplies to develop, validate and introduce
laboratory-developed tests to clinicians in the United States and Canada.
See full press release
Market News and Data brought to you by Benzinga APIs© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in